About Genpro Research
Genpro Research is a Technology company based in Waltham (United States) founded in 2016, and was acquired by Catalyst Clinical Research in July 2023. NLP, software development, and big data services are provided. The company has 126 employees. Its website genproresearch.com draws about 15 thousand monthly visits. Its Indian entity Flex And Oncology Clinical Research Private Limited reported revenue of ₹33.24 Cr. Its focus areas include Business Services, AI Services, Consulting and Natural Language Processing. Its competitors include Tredence, Cigniti and Nara Logics; 2 of its 3 listed competitors have raised funding.
Company details
Genpro Research was founded in 2016 and is based in Waltham, United States. Operations are centered on the technology sector, where natural language processing, software development, and big data services are delivered to clients. The company supports various applications through its domain expertise, with activities conducted primarily in the U.S. market. Focus remains on practical implementations of these technologies for business needs.
- Headquarters Waltham, United States
- Employees 126
- Stage Acquired
- SectorsTechnology
- Website genproresearch.com
- Social LinkedIn X Facebook
- Acquired by Catalyst Clinical Research (Jul 2023)
- Legal Name Flex And Oncology Clinical Research Private Limited
- Date of Incorporation 04 Jul, 2019
- Jurisdiction Thiruvananthapuram, Kerala, India
- Indian entity revenue₹33.24 Cr
FY 2025 · +41% YoY
- Indian entity net profit₹1.71 Cr
FY 2025 · 5% margin
- Indian entity EBITDA₹2.98 Cr
FY 2025 · 9% margin
- Investors
- Employee Count126
- Acquired byCatalyst Clinical Research
(Jul 2023)
Associated legal entities of Genpro Research
Genpro Research is associated with 2 registered companies on The Company Check; the primary company is Flex And Oncology Clinical Research Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Flex And Oncology Clinical Research Private Limited CIN U72900KL2019PTC058663 | Active | 04 Jul 2019 | Thiruvananthapuram, Kerala | ₹33.2 Cr | 126 | 2 | View details |
| Genpro Life Sciences India Private Limited CIN U74999KL2016PTC047322 | Active | 21 Nov 2016 | Thiruvananthapuram, Kerala | ₹0.1 Cr | 2 | View details |
Investors in Genpro Research
Genpro Research has secured backing from 1 investor. Prominent investors backing the company include Catalyst Clinical Research.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Full-service clinical research organization | 2013 | catalystcr.com | Durham, United States |
Investor details for Genpro Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Flex And Oncology Clinical Research Private Limited (Genpro Research)
Flex And Oncology Clinical Research Private Limited is the primary company behind Genpro Research. The boards of the 2 registered companies of Genpro Research currently have 3 directors; the longest-serving is Anoop Parameswarakurup Ambika, appointed in 2016. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anoop Parameswarakurup Ambika DIN 00425436 | Director | 21 Nov 2016 | 9 yrs 11 mo | Genpro Life Sciences India Private Limited |
| Sindhu Bhaskaran Pillai DIN 07577845 | Director | 10 Jan 2019 | 7 yrs 9 mo | Genpro Life Sciences India Private Limited, Flex And Oncology Clinical Research Private Limited |
| Patricia Bronke Mcnamara DIN 10450467 | Director | 28 Oct 2024 | 2 yrs | Flex And Oncology Clinical Research Private Limited |
People of Genpro Research
9 people are tracked at Genpro Research (5 in leadership, 4 in board & advisors); the tracked headcount is 126.
| Name | Role | Group |
|---|---|---|
Gheorghe Doros | Director, Statistical Consulting | Leadership |
| Director, India Operations | Leadership | |
Shariq Alavi | VP, Business Development | Leadership |
Kapil Khambholja | Chief Scientific Officer | Leadership |
Karim Abdelrazek | Director Of Business Development | Leadership |
Mark Chang | Scientific Advisor | Board & advisors |
Babu Sivadasan | Scientific Advisor | Board & advisors |
Paul Azunre | Scientific Advisor | Board & advisors |
Philip T. Lavin | Scientific Advisor | Board & advisors |
Complete people profiles for Genpro Research
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Genpro Research
Figures of Flex And Oncology Clinical Research Private Limited, the primary company behind Genpro Research, for FY 2025. Revenue was ₹33.24 Cr (+41% year on year). Net profit was ₹1.71 Cr (5% margin). EBITDA was ₹2.98 Cr (9% margin). Revenue has grown at a compounded annual rate of +63% over three years and +73% over five years.
- ₹33.24 CrRevenue · FY 2025 · +41% YoY
- ₹1.71 CrNet profit · 5% margin
- ₹2.98 CrEBITDA · 9% margin
- ₹10,000Paid-up capital
- 126Employees (provident fund records)
- +63%Revenue CAGR, 3 years
- +73%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Flex And Oncology Clinical Research Private Limited are on its company page.
Detailed financial statements for Genpro Research
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Genpro Research
2 dated milestones of Genpro Research across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Genpro Research is founded.
- Exit Acquired by Catalyst Clinical Research.
Competitors of Genpro Research
Genpro Research has 3 listed competitors in our database, 2 of them funded. They include Tredence, Cigniti and Nara Logics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tredence.com | 2013 | San Jose, United States | $205M | AI consulting, supply chain, and customer analytics services are provided. | ||
| cigniti.com | 1998 | Irving, United States | 3,557 | Independent software testing services are provided with proprietary tools. | ||
| naralogics.com | 2011 | Boston, United States | $18.47M | 16 | AI and natural language processing services are provided. |
Detailed competitors of Genpro Research
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Genpro Research
The website of Genpro Research (genproresearch.com) receives about 15.5K visits a month.
- Monthly visits15.5K
Top companies in AI Core Platforms & Infrastructure
3 companies that operate in the same segment as Genpro Research (AI Core Platforms & Infrastructure) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Platform that provides data analysis and management solutions | 2003 | Denver, Colorado, United States | USD 2.46 B | USD 2.87 B | 5,915 | |
OpenAI is engaged in developing advanced artificial intelligence technologies. | 2015 | San Francisco, California, United States | USD 180.07 B | 11,115 | ||
AI models and chatbots are offered for industry applications. | 2021 | San Francisco, California, United States | USD 132.31 B | 6,146 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genpro Research
Complete news archive for Genpro Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genpro Research
Genpro Research was founded in 2016.
Genpro Research is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Genpro Research has 126 employees.
The primary company behind Genpro Research, Flex And Oncology Clinical Research Private Limited, reported revenue of ₹33.24 Cr for FY 2025, up 41% year on year.
Genpro Research was founded in 2016 and is based in Waltham, United States. Operations are centered on the technology sector, where natural language processing, software development, and big data services are delivered to clients. The company supports various applications through its domain expertise, with activities conducted primarily in the U.S. market. Focus remains on practical implementations of these technologies for business needs.
Genpro Research's top competitors include Tredence, Cigniti and Nara Logics.
Genpro Research has 1 investor. Key investors include Catalyst Clinical Research.
Genpro Research is associated with 2 legal entities: Flex And Oncology Clinical Research Private Limited, Genpro Life Sciences India Private Limited.
Yes. Genpro Research was acquired by Catalyst Clinical Research in July 2023.
The legal entities of Genpro Research currently have 3 directors, including Sindhu Bhaskaran Pillai, Anoop Parameswarakurup Ambika, Patricia Bronke Mcnamara.